{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:13:07Z","timestamp":1762431187733},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T00:00:00Z","timestamp":1468886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00330-016-4475-3","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T11:17:01Z","timestamp":1468927021000},"page":"1676-1684","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin"],"prefix":"10.1007","volume":"27","author":[{"given":"Philipp M.","family":"Kazmierczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Rominger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Wenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Spitzweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Auernhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin K.","family":"Angele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Rist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens C.","family":"Cyran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,19]]},"reference":[{"key":"4475_CR1","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","volume":"379","author":"N Pavlidis","year":"2012","unstructured":"Pavlidis N, Pentheroudakis G (2012) Cancer of unknown primary site. Lancet 379:1428\u20131435","journal-title":"Lancet"},{"key":"4475_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.seminoncol.2008.10.009","volume":"36","author":"KA Oien","year":"2009","unstructured":"Oien KA (2009) Pathologic evaluation of unknown primary cancer. Semin Oncol 36:8\u201337","journal-title":"Semin Oncol"},{"key":"4475_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrclinonc.2011.158","volume":"8","author":"C Massard","year":"2011","unstructured":"Massard C, Loriot Y, Fizazi K (2011) Carcinomas of an unknown primary origin \u2013 diagnosis and treatment. Nat Rev Clin Oncol 8:701\u2013710","journal-title":"Nat Rev Clin Oncol"},{"key":"4475_CR4","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/annonc\/mdr536","volume":"23","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Bevier M, Hemminki A, Sundquist J (2012) Survival in cancer of unknown primary site: population-based analysis by site and histology. Ann Oncol 23:1854\u20131863","journal-title":"Ann Oncol"},{"key":"4475_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00117-013-2547-9","volume":"54","author":"PM Kazmierczak","year":"2014","unstructured":"Kazmierczak PM, Nikolaou K, Rominger A, Graser A, Reiser MF, Cyran CC (2014) Radiological diagnostics in CUP syndrome. Radiologe 54:117\u2013123","journal-title":"Radiologe"},{"key":"4475_CR6","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1634\/theoncologist.2011-0449","volume":"17","author":"AK Moller","year":"2012","unstructured":"Moller AK, Loft A, Berthelsen AK et al (2012) A prospective comparison of 18F-FDG PET\/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site. Oncologist 17:1146\u20131154","journal-title":"Oncologist"},{"key":"4475_CR7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jama.1982.03330030046024","volume":"248","author":"PR Karsell","year":"1982","unstructured":"Karsell PR, Sheedy PF 2nd, O'Connell MJ (1982) Computed tomography in search of cancer of unknown origin. JAMA 248:340\u2013343","journal-title":"JAMA"},{"key":"4475_CR8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1148\/radiol.14141073","volume":"274","author":"JR Lee","year":"2015","unstructured":"Lee JR, Kim JS, Roh JL et al (2015) Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET\/CT with contrast-enhanced CT or CT\/MR imaging \u2013 prospective study. Radiology 274:764\u2013771","journal-title":"Radiology"},{"key":"4475_CR9","first-page":"8941","volume":"7","author":"U Elboga","year":"2014","unstructured":"Elboga U, Kervancioglu S, Sahin E, Basibuyuk M, Celen YZ, Aktolun C (2014) Utility of F-18 fluorodeoxyglucose positron emission tomography\/computed in carcinoma of unknown primary. Int J Clin Exp Pathol 7:8941\u20138946","journal-title":"Int J Clin Exp Pathol"},{"key":"4475_CR10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.canep.2012.03.002","volume":"36","author":"A Han","year":"2012","unstructured":"Han A, Xue J, Hu M, Zheng J, Wang X (2012) Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. Cancer Epidemiol 36:470\u2013475","journal-title":"Cancer Epidemiol"},{"key":"4475_CR11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000335629","volume":"95","author":"UF Pape","year":"2012","unstructured":"Pape UF, Perren A, Niederle B et al (2012) ENETS Consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology 95:135\u2013156","journal-title":"Neuroendocrinology"},{"key":"4475_CR12","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/cncr.23469","volume":"112","author":"I Kayani","year":"2008","unstructured":"Kayani I, Bomanji JB, Groves A et al (2008) Functional imaging of neuroendocrine tumors with combined PET\/CT using 68Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer 112:2447\u20132455","journal-title":"Cancer"},{"key":"4475_CR13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamasurg.2014.216","volume":"149","author":"EK Bergsland","year":"2014","unstructured":"Bergsland EK, Nakakura EK (2014) Neuroendocrine tumors of unknown primary: is the primary site really not known? JAMA Surg 149:889\u2013890","journal-title":"JAMA Surg"},{"key":"4475_CR14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/00365521.2015.1033454","volume":"50","author":"A Kjaer","year":"2015","unstructured":"Kjaer A, Knigge U (2015) Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors. Scand J Gastroenterol 50:740\u2013747","journal-title":"Scand J Gastroenterol"},{"key":"4475_CR15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.critrevonc.2015.11.003","volume":"98","author":"B Rossana","year":"2016","unstructured":"Rossana B, Silvia R, Mariangela T et al (2016) Gastrointestinal neuroendocrine tumors: searching the optimal treatment strategy \u2013 a literature review. Crit Rev Oncol Hematol 98:264\u2013274","journal-title":"Crit Rev Oncol Hematol"},{"key":"4475_CR16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12149-014-0856-3","volume":"28","author":"O Alonso","year":"2014","unstructured":"Alonso O, Rodriguez-Taroco M, Savio E, Bentancourt C, Gambini JP, Engler H (2014) (68)Ga-DOTATATE PET\/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin. Ann Nucl Med 28:638\u2013645","journal-title":"Ann Nucl Med"},{"key":"4475_CR17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","volume":"35","author":"MS Hofman","year":"2015","unstructured":"Hofman MS, Lau WF, Hicks RJ (2015) Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics 35:500\u2013516","journal-title":"Radiographics"},{"key":"4475_CR18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00259-004-1702-y","volume":"32","author":"WA Breeman","year":"2005","unstructured":"Breeman WA, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP (2005) Radiolabelling DOTA-peptides with 68Ga. Eur J Nucl Med Mol Imaging 32:478\u2013485","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4475_CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/RLU.0b013e31823ea730","volume":"37","author":"N Naswa","year":"2012","unstructured":"Naswa N, Sharma P, Kumar A et al (2012) (68)Ga-DOTANOC PET\/CT in patients with carcinoma of unknown primary of neuroendocrine origin. Clin Nucl Med 37:245\u2013251","journal-title":"Clin Nucl Med"},{"key":"4475_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00259-009-1205-y","volume":"37","author":"V Prasad","year":"2010","unstructured":"Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP (2010) Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET\/CT. Eur J Nucl Med Mol Imaging 37:67\u201377","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4475_CR21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00259-009-1349-9","volume":"37","author":"V Ambrosini","year":"2010","unstructured":"Ambrosini V, Nanni C, Zompatori M et al (2010) (68)Ga-DOTA-NOC PET\/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 37:722\u2013727","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4475_CR22","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/gut.2009.204453","volume":"60","author":"CJ Auernhammer","year":"2011","unstructured":"Auernhammer CJ, Goke B (2011) Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum\/ileum and pancreatic origin. Gut 60:1009\u20131021","journal-title":"Gut"},{"key":"4475_CR23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1677\/ERC-09-0042","volume":"16","author":"A Ahmed","year":"2009","unstructured":"Ahmed A, Turner G, King B et al (2009) Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer 16:885\u2013894","journal-title":"Endocr Relat Cancer"},{"key":"4475_CR24","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00268-002-6630-z","volume":"26","author":"P Hellman","year":"2002","unstructured":"Hellman P, Lundstrom T, Ohrvall U et al (2002) Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg 26:991\u2013997","journal-title":"World J Surg"},{"key":"4475_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000324770","volume":"93","author":"G Capurso","year":"2011","unstructured":"Capurso G, Bettini R, Rinzivillo M, Boninsegna L, Delle Fave G, Falconi M (2011) Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review. Neuroendocrinology 93:223\u2013229","journal-title":"Neuroendocrinology"},{"key":"4475_CR26","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","volume":"26","author":"ME Caplin","year":"2015","unstructured":"Caplin ME, Baudin E, Ferolla P et al (2015) Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol 26:1604\u20131620","journal-title":"Ann Oncol"},{"key":"4475_CR27","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2217\/fon.14.139","volume":"10","author":"CB Johnbeck","year":"2014","unstructured":"Johnbeck CB, Knigge U, Kjaer A (2014) PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature. Future Oncol 10:2259\u20132277","journal-title":"Future Oncol"},{"key":"4475_CR28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00259-012-2123-y","volume":"39","author":"L Kabasakal","year":"2012","unstructured":"Kabasakal L, Demirci E, Ocak M et al (2012) Comparison of (68)Ga-DOTATATE and (68)Ga-DOTANOC PET\/CT imaging in the same patient group with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 39:1271\u20131277","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4475_CR29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/RLI.0b013e3181afbb36","volume":"44","author":"TC Kwee","year":"2009","unstructured":"Kwee TC, van Ufford HM, Beek FJ et al (2009) Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Invest Radiol 44:683\u2013690","journal-title":"Invest Radiol"},{"key":"4475_CR30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jso.23833","volume":"111","author":"NJ Look Hong","year":"2015","unstructured":"Look Hong NJ, Petrella T, Chan K (2015) Cost-effectiveness analysis of staging strategies in patients with regionally metastatic melanoma. J Surg Oncol 111:423\u2013430","journal-title":"J Surg Oncol"},{"key":"4475_CR31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/0284185115579932","volume":"57","author":"AD Baur","year":"2016","unstructured":"Baur AD, Pavel M, Prasad V, Denecke T (2016) Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment. Acta Radiol 57:260\u2013270","journal-title":"Acta Radiol"},{"key":"4475_CR32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2967\/jnumed.110.083741","volume":"52","author":"J Ruf","year":"2011","unstructured":"Ruf J, Schiefer J, Furth C et al (2011) 68Ga-DOTATOC PET\/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol. J Nucl Med 52:697\u2013704","journal-title":"J Nucl Med"},{"key":"4475_CR33","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s00330-013-2929-4","volume":"23","author":"R Manfredi","year":"2013","unstructured":"Manfredi R, Bonatti M, Mantovani W et al (2013) Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour. Eur Radiol 23:3029\u20133039","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-016-4475-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4475-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T10:45:26Z","timestamp":1568198726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-016-4475-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,19]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["4475"],"URL":"https:\/\/doi.org\/10.1007\/s00330-016-4475-3","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,19]]}}}